diabetes

February 10, 2022

New insights into hypothalamic obesity

A common Type 2 diabetes treatment being tested for hypothalamic obesity had unexpected results on weight loss and total energy expenditure, Vanderbilt researchers report.

By VUMC News and Communications
January 31, 2022

Impact of digital health interventions

Vanderbilt researchers test and recommend statistical approaches to study the association between engagement with digital health interventions and clinical outcomes.

By Leigh MacMillan
January 13, 2022

Eighteen years ago Kanisha Sizemore got a new kidney and pancreas. With her job in the Transplant Pharmacy she gives patients hope and perspective.

“Being a transplant recipient is a blessing, but it is also life changing in several ways.”

By Matt Batcheldor
VUMC clinicians are seeing a connection between how much time children spend in front of screens and a host of adverse health conditions.
January 12, 2022

Excessive screen time impacting health of children in many ways

Vanderbilt physicians are seeing an increasing trend of health conditions in children with chronic diseases like diabetes, directly or indirectly related to excessive screen time.

By Nancy Humphrey
Insulin in vials
November 11, 2021

New way to bEET insulin resistance

Signaling molecules called EETs could improve insulin resistance, a primary risk factor for Type 2 diabetes and cardiovascular disease, Vanderbilt researchers have discovered.

By Bill Snyder
November 11, 2021

International gathering scrutinizes immune response, beta cell biology in Type 1 diabetes

By Jill Clendening
August 27, 2021

Study proves standardized protocol can support reliable MRI use for multisite pancreatic research

Researchers with the Vanderbilt Diabetes Research and Training Center (DRTC) at Vanderbilt University Medical Center led a multisite study which has demonstrated that, when controlled and standardized, quantitative magnetic resonance imaging (MRI) of the pancreas is highly reproducible when using different MRI hardware and software at different geographic locations.
By Jill Clendening
August 24, 2021

Autoimmunity advance

Vanderbilt researchers have developed a high-throughput screening method to identify and characterize antigen-specific B cells — potential biomarkers for autoimmune disease and targets for new treatments.
By Leigh MacMillan
August 5, 2021

Gene expression in diabetic nephropathy

Vanderbilt researchers are looking to mRNA populations in podocytes — kidney cells that help filter blood — to help identify potential targets for treating diabetic kidney disease.
By Shivani Sharma
July 15, 2021

Study shows continuous glucose monitors improve management of type 2 diabetes

For patients with type 2 diabetes treated with basal or long-acting insulin, the use of continuous glucose monitors (CGMs) can result in significantly lower hemoglobin A1C (a blood test that reflects average blood glucose levels over three months), and better management of the disease according to a study recently published in the journal JAMA.
By Jill Clendening
May 20, 2021

Beta cell regeneration

Vanderbilt researchers dissected the complex microenvironment of the pancreatic islet to discover the signals that drive beta cell regeneration — as a possible treatment for diabetes.
By Leigh MacMillan
May 20, 2021

Type 2 diabetes medication shown to benefit asthma patients

Type 2 diabetes patients who also have asthma are benefitting from a diabetes medication, typically given to help the pancreas produce more insulin, that also improves asthma symptoms and may reduce lung and airway inflammation.
By Craig Boerner
March 18, 2021

HIV, diabetes and immune cells in fat

In HIV-positive individuals with diabetes, immune cells in fat are more proinflammatory and cytotoxic and may represent a therapeutic target for diabetes.
By Leigh MacMillan
1 … 3 4 5 6 7 … 18